RCUS logo

Arcus Biosciences (RCUS) Operating profit

annual operating profit:

-$310.00M+$30.00M(+8.82%)
December 31, 2024

Summary

  • As of today (June 17, 2025), RCUS annual operating income is -$310.00 million, with the most recent change of +$30.00 million (+8.82%) on December 31, 2024.
  • During the last 3 years, RCUS annual operating profit has fallen by -$364.00 million (-674.07%).
  • RCUS annual operating profit is now -674.07% below its all-time high of $54.00 million, reached on December 31, 2021.

Performance

RCUS Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUSincome statement metrics

quarterly operating profit:

-$122.00M-$19.00M(-18.45%)
March 31, 2025

Summary

  • As of today (June 17, 2025), RCUS quarterly operating income is -$122.00 million, with the most recent change of -$19.00 million (-18.45%) on March 31, 2025.
  • Over the past year, RCUS quarterly operating profit has dropped by -$126.00 million (-3150.00%).
  • RCUS quarterly operating profit is now -143.41% below its all-time high of $281.02 million, reached on December 31, 2021.

Performance

RCUS quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUSincome statement metrics

TTM operating profit:

-$436.00M-$126.00M(-40.65%)
March 31, 2025

Summary

  • As of today (June 17, 2025), RCUS TTM operating income is -$436.00 million, with the most recent change of -$126.00 million (-40.65%) on March 31, 2025.
  • Over the past year, RCUS TTM operating profit has dropped by -$186.00 million (-74.40%).
  • RCUS TTM operating profit is now -681.19% below its all-time high of $75.02 million, reached on September 30, 2022.

Performance

RCUS TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUSincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

RCUS Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.8%-3150.0%-74.4%
3 y3 years-674.1%-82.1%-829.7%
5 y5 years-249.5%-329.6%-343.4%

RCUS Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-674.1%+8.8%-3150.0%at low-681.2%at low
5 y5-year-674.1%+8.8%-143.4%at low-681.2%at low
alltimeall time-674.1%+8.8%-143.4%at low-681.2%at low

RCUS Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$122.00M(+18.4%)
-$436.00M(+40.6%)
Dec 2024
-$310.00M(-8.8%)
-$103.00M(-1.9%)
-$310.00M(+4.0%)
Sep 2024
-
-$105.00M(-0.9%)
-$298.00M(+9.2%)
Jun 2024
-
-$106.00M(-2750.0%)
-$273.00M(+9.2%)
Mar 2024
-
$4.00M(-104.4%)
-$250.00M(-26.5%)
Dec 2023
-$340.00M(+21.4%)
-$91.00M(+13.8%)
-$340.00M(+5.3%)
Sep 2023
-
-$80.00M(-3.6%)
-$323.00M(+3.2%)
Jun 2023
-
-$83.00M(-3.5%)
-$313.00M(+4.7%)
Mar 2023
-
-$86.00M(+16.2%)
-$299.00M(+6.8%)
Dec 2022
-$280.00M(-618.5%)
-$74.00M(+5.7%)
-$280.00M(-473.2%)
Sep 2022
-
-$70.00M(+1.4%)
$75.02M(+12.2%)
Jun 2022
-
-$69.00M(+3.0%)
$66.88M(+11.9%)
Mar 2022
-
-$67.00M(-123.8%)
$59.75M(+10.6%)
Dec 2021
$54.00M(-143.5%)
$281.02M(-459.7%)
$54.00M(-119.4%)
Sep 2021
-
-$78.14M(+2.6%)
-$278.80M(+40.0%)
Jun 2021
-
-$76.14M(+4.7%)
-$199.11M(+18.3%)
Mar 2021
-
-$72.75M(+40.5%)
-$168.35M(+35.8%)
DateAnnualQuarterlyTTM
Dec 2020
-$124.00M(+39.8%)
-$51.78M(-3436.1%)
-$124.00M(+38.2%)
Sep 2020
-
$1.55M(-103.4%)
-$89.75M(-21.7%)
Jun 2020
-
-$45.38M(+59.8%)
-$114.55M(+16.5%)
Mar 2020
-
-$28.40M(+62.0%)
-$98.34M(+10.9%)
Dec 2019
-$88.71M(+61.7%)
-$17.53M(-24.6%)
-$88.71M(+4.8%)
Sep 2019
-
-$23.25M(-20.3%)
-$84.67M(+15.1%)
Jun 2019
-
-$29.16M(+55.3%)
-$73.56M(+22.0%)
Mar 2019
-
-$18.77M(+39.2%)
-$60.30M(+9.9%)
Dec 2018
-$54.86M(+2.7%)
-$13.48M(+11.0%)
-$54.86M(+0.3%)
Sep 2018
-
-$12.14M(-23.6%)
-$54.72M(-16.7%)
Jun 2018
-
-$15.90M(+19.3%)
-$65.71M(+10.5%)
Mar 2018
-
-$13.33M(-0.1%)
-$59.47M(+11.3%)
Dec 2017
-$53.44M(+193.9%)
-$13.34M(-42.3%)
-$53.44M(+33.3%)
Sep 2017
-
-$23.13M(+139.4%)
-$40.10M(+136.4%)
Jun 2017
-
-$9.66M(+32.4%)
-$16.96M(+132.4%)
Mar 2017
-
-$7.30M
-$7.30M
Dec 2016
-$18.18M
-
-

FAQ

  • What is Arcus Biosciences annual operating income?
  • What is the all time high annual operating profit for Arcus Biosciences?
  • What is Arcus Biosciences annual operating profit year-on-year change?
  • What is Arcus Biosciences quarterly operating income?
  • What is the all time high quarterly operating profit for Arcus Biosciences?
  • What is Arcus Biosciences quarterly operating profit year-on-year change?
  • What is Arcus Biosciences TTM operating income?
  • What is the all time high TTM operating profit for Arcus Biosciences?
  • What is Arcus Biosciences TTM operating profit year-on-year change?

What is Arcus Biosciences annual operating income?

The current annual operating profit of RCUS is -$310.00M

What is the all time high annual operating profit for Arcus Biosciences?

Arcus Biosciences all-time high annual operating income is $54.00M

What is Arcus Biosciences annual operating profit year-on-year change?

Over the past year, RCUS annual operating income has changed by +$30.00M (+8.82%)

What is Arcus Biosciences quarterly operating income?

The current quarterly operating profit of RCUS is -$122.00M

What is the all time high quarterly operating profit for Arcus Biosciences?

Arcus Biosciences all-time high quarterly operating income is $281.02M

What is Arcus Biosciences quarterly operating profit year-on-year change?

Over the past year, RCUS quarterly operating income has changed by -$126.00M (-3150.00%)

What is Arcus Biosciences TTM operating income?

The current TTM operating profit of RCUS is -$436.00M

What is the all time high TTM operating profit for Arcus Biosciences?

Arcus Biosciences all-time high TTM operating income is $75.02M

What is Arcus Biosciences TTM operating profit year-on-year change?

Over the past year, RCUS TTM operating income has changed by -$186.00M (-74.40%)
On this page